Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. Genus plc
  6. Summary
    GNS   GB0002074580

GENUS PLC

(GNS)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed London Stock Exchange
07/29/2021 07/30/2021 08/02/2021 08/03/2021 08/04/2021 Date
5500(c) 5515(c) 5620(c) 5715(c) 5730 Last
83 532 66 746 46 594 40 172 7 372 Volume
-1.08% +0.27% +1.90% +1.69% +0.26% Change
More quotes
Estimated financial data (e)
Sales 2021 569 M 792 M 792 M
Net income 2021 51,1 M 71,1 M 71,1 M
Net Debt 2021 82,0 M 114 M 114 M
P/E ratio 2021 72,7x
Yield 2021 0,54%
Sales 2022 609 M 849 M 849 M
Net income 2022 60,4 M 84,1 M 84,1 M
Net Debt 2022 74,2 M 103 M 103 M
P/E ratio 2022 62,4x
Yield 2022 0,59%
Capitalization 3 698 M 5 139 M 5 153 M
EV / Sales 2021 6,65x
EV / Sales 2022 6,19x
Nbr of Employees 3 100
Free-Float 99,3%
More Financials
Company
Genus plc is an animal genetics company, which provides farmers with genetics that enable them to produce animal protein, in the form of meat and milk. The Company's segments include Genus PIC, Genus ABS, Genus Asia, and Research and Development. The Genus PIC segment is engaged in porcine sales business, excluding Asia, and serves porcine customers in North America, Latin America and Europe. The Genus ABS segment... 
More about the company
Ratings of Genus plc
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B-
More Ratings
All news about GENUS PLC
06/22Genus Seeks Acquisitions
CI
06/22GENUS : Says Gene-Edited Animals 100% Resistant To Blue-Ear Pig Disease
MT
06/22GENUS PLC TO HOLD CAPITAL MARKETS EV : 00 AM ET and Provide Update on its Porcin..
BU
05/31GENUS POWER INFRASTRUCTURES' : Consolidated Net Profit Surges in Fiscal Q4
MT
03/31GENUS : Stifel Downgrades Genus to Hold From Buy
MT
03/22Genus plc Announces Board Changes
CI
03/04GENUS PLC : Ex-dividend day for interim dividend
FA
02/25GENUS : UK firm Genus sees challenges as it restocks China pig farms
RE
02/25GENUS : Boosts Interim Dividend by 10% as Profit Grows
MT
02/25GENUS PLC : Reports Interim First Half 2021 Fiscal Year Results
BU
02/25Genus plc Reports Earnings Results for the Half Year Ended December 31, 2020
CI
02/25Genus plc Declares an Interim Dividend for the Year 2021 Payable on 1 April 2..
CI
02/25Genus plc Provides Earnings Guidance for the Year 2021
CI
01/22BOSTON SCIENTIFIC : Gets FDA OK for Vercise Genus Deep Brain Stimulation System
DJ
01/18GENUS : Estimates Fiscal H1 Profit to Rise Up to $66 Million
MT
More news
News in other languages on GENUS PLC
2020Trois actions approuvées par nos amies les bêtes
More news
Analyst Recommendations on GENUS PLC
More recommendations
Chart GENUS PLC
Duration : Period :
Genus plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GENUS PLC
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 7
Last Close Price 5 715,00 GBX
Average target price 5 307,00 GBX
Spread / Average Target -7,14%
EPS Revisions
Managers and Directors
Stephen Wilson Chief Executive Officer & Executive Director
Alison Henriksen Chief Financial Officer & Director
Iain G. T. Ferguson Non-Executive Chairman
Elena Rice Chief Scientific Officer
Bill Christianson Chief Operating Officer
Sector and Competitors
1st jan.Capi. (M$)
GENUS PLC36.20%5 139
MODERNA, INC.269.97%155 195
LONZA GROUP AG26.48%59 070
IQVIA HOLDINGS INC.39.52%47 899
CELLTRION, INC.-26.18%31 463
SEAGEN INC.-9.68%28 780